ATLANTA, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC informs investors that a shareholder class action lawsuit has been filed against Outlook Therapeutics, Inc. ("Outlook Therapeutics" or "the Company") (NASDAQ:OTLK). The lawsuit alleges Outlook Therapeutics made false or misleading statements and/or omitted material adverse information regarding the Company's business, operations, and prospects, including: (i) there was a lack of substantial evidence supporting ONS-5010 as a treatment for wet AMD; (ii) the Company and/or its manufacturing partner had deficient chemistry manufacturing and controls ("CMC") and other manufacturing issues for ONS-5010, which remained unresolved at the time the ONS-5010 BLA was resubmitted ...

Full story available on Benzinga.com